CompletedNot Applicable

Building on Needle Exchange to Optimize Prevention & Treatment

United States720 participantsStarted 2018-06-22

Plain-language summary

There are several biomedical interventions that can help people who inject drugs (particularly those with or at risk for HIV), but these services often do not get to the people most in need. In this project investigators propose to determine if delivery of these services to PWID by an integrated care van that is linked to a mobile syringe service program improves clinical outcomes, is feasible and sustainable, and is cost-effective.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * If HIV-positive: report history of injection drug use * If HIV-negative: injected drugs ≥ 4 days in the last 30 days or shared a needle or syringe in the last 6 months Exclusion Criteria: * Not competent to provide written informed consent * Not willing or able to provide a blood specimen

What they're measuring

Composite PWID Score (Service Access, Risk Behaviors, Adverse Outcomes)

Timeframe: Between baseline visit and the V7 follow-up visit at 7 months

Trial details

NCT IDNCT03567174

SponsorJohns Hopkins University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-03-12

Results submitted2022-11-29

View on ClinicalTrials.gov More Intravenous Drug Usage trials